DataBase for Analysis of Rectal Cancer Oncological Results

CompletedOBSERVATIONAL

Enrollment

2,443

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

December 30, 2022

Study Completion Date

December 31, 2024

Conditions

Rectal CancerMetforminOverall SurvivalLymph Node MetastasesDisease-free Survival

Interventions

DRUG

Metformin

Metformin use before operation due to previously diagnosed diabetes.

Trial Locations (1)

1st Department of General Surgery, Krakow

All Listed Sponsors

lead

Jagiellonian University

OTHER

NCT04947020 - DataBase for Analysis of Rectal Cancer Oncological Results | Biotech Hunter | Biotech Hunter